WC
TEVA icon

Whitney & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Whitney & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,425
Closed -$479K – 116
2017
Q3 		$479K Hold
14,425
– – 0.16% 85
2017
Q2 		$479K Sell
14,425
-1,950
-12% -$60.4K 0.16% 88
2017
Q1 		$525K Sell
16,375
-3,500
-18% -$119K 0.19% 76
2016
Q4 		$720K Sell
19,875
-6,950
-26% -$277K 0.27% 73
2016
Q3 		$1.23M Sell
26,825
-825
-3% -$43K 0.49% 63
2016
Q2 		$1.39M Sell
27,650
-900
-3% -$47.9K 0.56% 58
2016
Q1 		$1.53M Sell
28,550
-825
-3% -$48.4K 0.66% 53
2015
Q4 		$1.93M Sell
29,375
-50
-0.2% -$3.09K 0.84% 50
2015
Q3 		$1.66M Sell
29,425
-700
-2% -$45.4K 0.75% 52
2015
Q2 		$1.78M Sell
30,125
-300
-1% -$18.5K 0.78% 51
2015
Q1 		$1.9M Hold
30,425
– – 0.85% 48
2014
Q4 		$1.75M Sell
30,425
-450
-1% -$25.1K 0.78% 51
2014
Q3 		$1.66M Sell
30,875
-300
-1% -$15.9K 0.77% 55
2014
Q2 		$1.63M Sell
31,175
-650
-2% -$33.2K 0.75% 55
2014
Q1 		$1.68M Sell
31,825
-1,900
-6% -$87.8K 0.85% 50
2013
Q4 		$1.35M Sell
33,725
-4,175
-11% -$164K 0.75% 50
2013
Q3 		$1.43M Sell
37,900
-3,100
-8% -$121K 1% 43
2013
Q2 		$1.61M Buy
+41,000
New +$1.6M 1.17% 42

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Whitney & Co's TEVA Position: Q4 2017 in Review

Whitney & Co sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 14,425 shares — an estimated $479K sold.

Whitney & Co first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $1.93M in Q4 2015. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Whitney & Co reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Whitney & Co sold 14,425 Teva Pharmaceuticals shares in Q4 2017, an estimated $479K.
  • Whitney & Co first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Whitney & Co's Teva Pharmaceuticals position peaked at $1.93M in Q4 2015.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Whitney & Co's 13F filing for Q4 2017, filed 12 Feb 2018.